What Do Early Stage Life Science Companies Need to Grow?

[Sponsored] Scheduled for May 8 at 1 pm ET, the conversation will include Morgan Cheatham, head of healthcare and life sciences at Breyer Capital, Gurdane Bhutani,  founder and managing partner of MBX Capital, and will be moderated by Mercury Head of Healthcare and Life Sciences Ben Kromnick. The post What Do Early Stage Life Science…

Read More

From Scarcity to Possibility: What Perfusion Technologies Mean for the Organ Transplantation Industry

Machine perfusion extends the viability of organs outside the body by circulating oxygen and nutrients through a specialized solution. This means organs can travel greater distances, medical teams have more time to make thoughtful decisions and patients have a better chance of getting a match.  The post From Scarcity to Possibility: What Perfusion Technologies Mean…

Read More